Autoimmune diabetes is often misunderstood, misdiagnosed, or detected later than it should be. The key to identifying it early lies in specific autoimmune markers, particularly anti-Glutamate Decarboxylase (GAD), anti-Protein Tyrosine Phosphatase-like Protein IA-2 (IA-2), anti-Zinc transporter 8 (ZnT8), and anti-insulin autoantibody (IAA).
Logical Biological, biospecimen and critical raw material leader, and Bcell Design, pioneers in transgenic monoclonal antibody technology, today announced a long term strategic partnership to deliver engineered disease state materials for diagnostic and research markets.
High-titre biological materials play a vital role in the development and manufacturing of in vitro diagnostic (IVD) controls and calibrators. However, sourcing bulk high-titre disease state materials presents significant challenges for Quality Control and Calibrator Manufacturers. These obstacles impact downstream processes for IVD companies, and more importantly, the patients who awaiting testing, diagnosis, and treatment.
When it comes to manufacturing quality controls (QCs), choosing the right raw material is essential. With factors like supply sustainability, cost, and performance to be considered, how do you decide whether a native or engineered biological raw material is best?
Try a different search or visit our Biospecimen Product Table: Product Table